RECRUITING

Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to learn whether noise-augmented feedback using automatic speech recognition improves intelligibility and social participation in individuals with Parkinson's disease. The main questions the investigators will address are: Does noise-augmented feedback lead to increased intelligibility, as measured by transcription accuracy scores? Does a self-managed speech protocol lead to increased social participation, as measured by the Communicative Participation Item Bank and the Communicative Effectiveness Index questionnaires? Participants will: Receive 2-4 initial speech assessments in-person in our lab. Engage in speech treatment sessions at home using their phone and computer four days a week for four weeks. Four of those sessions will be directly monitored online by a speech-language pathologist. The rest of the sessions are completed by the participant. Come to the lab for two post-treatment assessments following completion of treatment. Come to the lab six months after treatment completion for an additional assessment.

Official Title

Understand Me for Life: Using Noise-augmented Automatic Speech Recognition to Improve Intelligibility in Parkinson's Disease

Quick Facts

Study Start:2024-09-01
Study Completion:2027-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06540989

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants will qualify for the study if:
  2. * They are 50-80 years old,
  3. * They have a medical diagnosis of PD,
  4. * They are within stages I-IV of Hoehn \& Yahr Scale,
  5. * Their antiparkinsonian medication schedule is stable,
  6. * They present with mild to moderate dysarthria,
  7. * They score ≥ 25 in the MMSE,
  8. * They score ≤ 24 in the BDI-III.
  1. * Participants will be excluded from the study if they:
  2. * Present with atypical parkinsonism at the time of screening (or other neurological condition),
  3. * Underwent neurosurgery treatment (DBS),
  4. * Received intensive voice-focused treatment less than three months prior to their involvement in the current study,
  5. * Present with any speech or voice pathology that is unrelated to PD.

Contacts and Locations

Study Contact

Gemma Moya-Galé, Ph.D.
CONTACT
212-678-3323
gm2446@tc.columbia.edu

Principal Investigator

Gemma Moya-Galé, Ph.D.
PRINCIPAL_INVESTIGATOR
Teachers College, Columbia University

Study Locations (Sites)

Teachers College, Columbia University
New York, New York, 10027
United States

Collaborators and Investigators

Sponsor: Teachers College, Columbia University

  • Gemma Moya-Galé, Ph.D., PRINCIPAL_INVESTIGATOR, Teachers College, Columbia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-01
Study Completion Date2027-06-30

Study Record Updates

Study Start Date2024-09-01
Study Completion Date2027-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Parkinson Disease